Detalhe da pesquisa
1.
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Cell
; 174(3): 758-769.e9, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30033370
2.
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Cell
; 175(3): 889, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30340047
3.
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.
Nature
; 608(7921): 199-208, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859180
4.
Batf stabilizes Th17 cell development via impaired Stat5 recruitment of Ets1-Runx1 complexes.
EMBO J
; 42(8): e109803, 2023 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917143
5.
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.
Prostate
; 84(8): 747-755, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544345
6.
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
Br J Cancer
; 130(1): 73-81, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951974
7.
Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
J Hepatol
; 80(1): 155-168, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940453
8.
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 385(12): 1091-1103, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161051
9.
Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study.
Future Oncol
; 20(10): 563-578, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38126311
10.
Accuracy of artificial intelligence-assisted growth prediction in skeletal Class I preadolescent patients using serial lateral cephalograms for a 2-year growth interval.
Orthod Craniofac Res
; 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321788
11.
Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial.
JAMA
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639723
12.
Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial.
JAMA
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639729
13.
Sex-specific associations between AD genotype and the microbiome of human amyloid beta knock-in (hAß-KI) mice.
Alzheimers Dement
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572865
14.
Genetic diversity promotes resilience in a mouse model of Alzheimer's disease.
Alzheimers Dement
; 20(4): 2794-2816, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426371
15.
The Abca7V1613M variant reduces Aß generation, plaque load, and neuronal damage.
Alzheimers Dement
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506634
16.
BIN1K358R suppresses glial response to plaques in mouse model of Alzheimer's disease.
Alzheimers Dement
; 20(4): 2922-2942, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460121
17.
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(6): 597-610, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269841
18.
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(4): 323-334, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990608
19.
Degenerate mapping of environmental location presages deficits in object-location encoding and memory in the 5xFAD mouse model for Alzheimer's disease.
Neurobiol Dis
; 176: 105939, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36462718
20.
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study Results.
Oncologist
; 28(5): e309-e312, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36994854